James Dahlman

James Dahlman is a professor in the Department of Biomedical Engineering at Georgia Tech and Emory Medical School. He studied CRISPR with Feng Zhang at the Broad Institute and received his PhD from MIT and Harvard Medical School, studying RNA delivery with Robert Langer. The Dahlman Lab works at the interface of drug delivery, nanotechnology, and genomics, in order to bridge big data and nanomedicine. James has won international awards at every stage of his career, most recently the MIT Tech Review TR35 and World Economic Forum top 10 Emerging Technologies. He has won young investigator awards from BMES, CMBE, Parkinson’s Foundation, and other organizations, and has published papers on drug delivery in Scientific American, Cell, Nature Biotechnology, Nature Nanotechnology, Nature Cell Biology, Nature Metabolism, Science Translational Medicine, Advanced Materials, JACS, PNAS, and other high-impact journals.